Elekta (OTCMKTS:EKTAY) Shares Gap Up – Here’s Why

Shares of Elekta AB (OTCMKTS:EKTAY) gapped up before the market opened on Wednesday. The stock had previously closed at $5.09, but opened at $5.2850. Elekta shares last traded at $5.28, with a volume of 2,088 shares traded.

Analyst Ratings Changes

Separately, Zacks Research upgraded Elekta from a “strong sell” rating to a “hold” rating in a research report on Tuesday, July 28th. One equities research analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Elekta presently has a consensus rating of “Hold”.

Elekta Price Performance

The business’s 50 day moving average is $5.33 and its two-hundred day moving average is $5.52. The company has a quick ratio of 0.62, a current ratio of 0.86 and a debt-to-equity ratio of 0.45. The firm has a market cap of $1.95 billion, a P/E ratio of -44.00 and a beta of 1.03.

Elekta (OTCMKTS:EKTAY) last announced its earnings results on Thursday, August 27th. The company reported $0.07 EPS for the quarter. The company had revenue of $372.30 million for the quarter. Elekta had a positive return on equity of 13.47% and a negative net margin of 2.38%. As a group, analysts anticipate that Elekta AB will post 0.43 earnings per share for the current year.

About Elekta

Elekta AB is a Sweden-based medical technology company that develops and supplies equipment, software and related services for radiation oncology and neurosurgery. Its technologies are used by hospitals and cancer treatment centers to plan and deliver precision radiation treatments for patients with cancer and neurological disorders.

The company’s portfolio includes linear accelerators, stereotactic radiosurgery systems, brachytherapy solutions, treatment-planning and oncology information software, and magnetic resonance-guided radiation therapy technology.